US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:100.18

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ramsay Health Care Lifts CEO Maximum LTI Opportunity

MT Newswires Live

HealthCo Healthcare and Wellness REIT Says Perth Hospital Completes Transition to New Operator

MT Newswires Live

Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval

Ramsay Health Care refreshes board with retirement of long-serving director and appointment of Dr Tracey Batten

FDA panel votes in favor of Grail’s Galleri benefits outweighing risks

Ramsay boosts CEO long-term incentive while holding base pay steady

FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says

Healthcare Stocks Fall

Gossamer Bio submits New Drug Application to FDA for seralutinib

MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter

Analyst Reiterates Buy on Viking as VK2735 Data Support Differentiated Obesity Franchise; $70 Price Target Maintained

Analysts Are Bullish on These Healthcare Stocks: Immunovant (IMVT), Oruka Therapeutics (ORKA)

Exchange-Traded Funds, US Equities Decline After Midday

MT Newswires Live

Stringer Reiterates Buy on Ionis as Late-Stage Pipeline Delivers; Price Target Maintained at $86

Worldwide Healthcare Trust Boosts Treasury Stock with New Share Buyback

Health Care Roundup: Market Talk

Bamboos Health Care Announces Final Dividend for FY2026

Sector Update: Healthcare

MT Newswires Live

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Market Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.055472560797593,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.055472560797593,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":100.18,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669043280","title":"Ramsay Health Care Lifts CEO Maximum LTI Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043280","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043280?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:51","pubTimestamp":1790207462,"startTime":"0","endTime":"0","summary":"Ramsay Health Care  has raised Group Chief Executive Natalie Davis' maximum long-term incentive  opportunity to 170% of fixed annual remuneration  from 150%, effective fiscal 2027, following a periodic review, according to a Thursday Australian bourse filing.The FAR remains unchanged at AU$1.8 million, while the short-term incentive remains unchanged at 100% of FAR at target and 150% at maximum, per the filing.The LTI will continue to be provided through performance rights, subject to vesting conditions and shareholder approval, while the existing 12-month restraint provision remains unchanged, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7113","BK7142","RHC.AU","BK4581","BK4588","XLV","BK4585","XBI","LABU","FAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669043402","title":"HealthCo Healthcare and Wellness REIT Says Perth Hospital Completes Transition to New Operator","url":"https://stock-news.laohu8.com/highlight/detail?id=2669043402","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669043402?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:44","pubTimestamp":1790207062,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT  said the Mount Private Hospital in Perth completed a transition of operations to Bethesda Health Care from Healthscope, according to a Thursday filing with the Australian bourse.The new long-term lease with Bethesda is guaranteed by the Western Australia state government, per the filing.The hospital is fully owned by the Unlisted Healthcare Fund, in which HealthCo Healthcare has a 49.6% interest.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLR.SI","BK4137","IVRA","XLV","SRT.SI","LABU","8C8U.SI","LU0128526141.USD","RJMG","YLDW","BK4585","DFRA","IQRA","BK4588","BK4581","BK7156","JJJ.SI","GLS.SI","LU0029874061.USD","BPRE","RNTY","BK6142","CFA.SI","BK7149","SRU.SI","PSCF","XBI","HCSG","HCW.AU","MDIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431216","title":"Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431216","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431216?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:35","pubTimestamp":1790202900,"startTime":"0","endTime":"0","summary":"Grail Inc. received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test.The cancer-detection company said the FDA's medical devices advisory committee voted 7-2, with one abstention, to greenlight a premarket approval application for Galleri.The FDA isn't bound to the committee's recommendation, but it takes them into consideration when making the final regulatory decision. The FDA is expected to make its final ruling on Galleri's premarket approval in the coming months.In three separate votes, the 10 voting members of the committee considered Galleri's safety, effectiveness and overall benefit-risk profile for screening and early detection of multiple types of cancer in adults aged 50 and older.The Galleri test is designed to detect cancer-specific methylation patterns shared by many types of cancer before symptoms appear, including cancers that don't have recommended screening today.When a cancer si","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4588","BK4585","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669311884","title":"Ramsay Health Care refreshes board with retirement of long-serving director and appointment of Dr Tracey Batten","url":"https://stock-news.laohu8.com/highlight/detail?id=2669311884","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669311884?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:12","pubTimestamp":1790201539,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) just unveiled an update. Ramsay Health Care announced that long-serving Non-Executive Director Michael Siddle will...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-refreshes-board-with-retirement-of-long-serving-director-and-appointment-of-dr-tracey-batten?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-refreshes-board-with-retirement-of-long-serving-director-and-appointment-of-dr-tracey-batten?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","XBI","BK4585","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669319284","title":"FDA panel votes in favor of Grail’s Galleri benefits outweighing risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669319284","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669319284?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:10","pubTimestamp":1790201424,"startTime":"0","endTime":"0","summary":"The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee voted to recommend approval for Grail’s (GRAL) Galleri, a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-panel-votes-in-favor-of-grails-galleri-benefits-outweighing-risks-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-panel-votes-in-favor-of-grails-galleri-benefits-outweighing-risks-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","BK4139","GRAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431944","title":"Ramsay boosts CEO long-term incentive while holding base pay steady","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431944","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431944?lang=en_us&edition=fundamental","pubTime":"2026-09-24 06:03","pubTimestamp":1790200986,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has provided an announcement. Ramsay Health Care has updated the remuneration structure for Group CEO and Managing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-boosts-ceo-long-term-incentive-while-holding-base-pay-steady?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-boosts-ceo-long-term-incentive-while-holding-base-pay-steady?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669431891","title":"FDA panel says Grail’s cancer detection blood test is safe, Bloomberg says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669431891","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669431891?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:30","pubTimestamp":1790199013,"startTime":"0","endTime":"0","summary":"17:26 EDT FDA panel says Grail’s (GRAL) cancer detection blood test is safe, Bloomberg says Published first on TheFly – the ultimate source for rea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-panel-says-grails-cancer-detection-blood-test-is-safe-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-panel-says-grails-cancer-detection-blood-test-is-safe-bloomberg-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4588","LABU","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669243961","title":"Healthcare Stocks Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2669243961","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669243961?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:04","pubTimestamp":1790197440,"startTime":"0","endTime":"0","summary":"A broad selloff in equities hit the healthcare sector amid growing concerns about sticky inflation and rising interest rates.Moderna MRNA CEO Stéphane Bancel said the company was never just about Covi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XLV","LU0029874061.USD","HCSG","BK4585","XBI","BK4137","LABU","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436661","title":"Gossamer Bio submits New Drug Application to FDA for seralutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436661?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:05","pubTimestamp":1790193939,"startTime":"0","endTime":"0","summary":"Gossamer Bio (GOSS) announced that it submitted a New Drug Application to the U.S. Food and Drug Administration in September 2026 for seralutinib f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gossamer-bio-submits-new-drug-application-to-fda-for-seralutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gossamer-bio-submits-new-drug-application-to-fda-for-seralutinib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","BK4588","GOSS","LABU","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436405","title":"MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436405","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436405?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:01","pubTimestamp":1790193660,"startTime":"0","endTime":"0","summary":"Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product Order Further Holds That Minimal-Manipulation Analysis Must Consider Tissue","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367829/0/en/mimedx-announces-favorable-federal-court-ruling-in-axiofill-regulatory-classification-matter.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435980","title":"Analyst Reiterates Buy on Viking as VK2735 Data Support Differentiated Obesity Franchise; $70 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435980?lang=en_us&edition=fundamental","pubTime":"2026-09-24 03:15","pubTimestamp":1790190924,"startTime":"0","endTime":"0","summary":"Viking Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Naz Rahman from Maxim Group reiterate...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-viking-as-vk2735-data-support-differentiated-obesity-franchise-70-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-viking-as-vk2735-data-support-differentiated-obesity-franchise-70-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438452","title":"Analysts Are Bullish on These Healthcare Stocks: Immunovant (IMVT), Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669438452?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:30","pubTimestamp":1790184615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Immunovant (IMVT) and Oruka Therapeutics (ORKA) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunovant-imvt-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-immunovant-imvt-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","ORKA","LABU","IMVT","LU0128526141.USD","XBI","BK4139","BK4585","BK4588","LU0320765992.SGD","HCSG","BK4137","LU0889565916.HKD","BK4581","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669383724","title":"Exchange-Traded Funds, US Equities Decline After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2669383724","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669383724?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:15","pubTimestamp":1790183756,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were lower. Actively traded Invesco QQQ Trust (QQQ) shed 1.2%.US equity indexes fell in midday trading on Wednesday as oil prices ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DGZ","IGLD","USG","UCO","CBOY","IAU","QQQ","ETH.USD.CC","QID","IGM","QLD","GPIQ","SETH","BK4581","XLI","BTF","CBXA","ETHD","UGL","BTC.USD.CC","BITB","GLL","XLK","EETH","KGLD","BK4588","CBTA","QQQX","SBIT","CBOJ","BGLD","NJUL","SOXL","VDC","PSQ","TETH","YGLD","ETHT","SOXX","DFII","BITX","QDEC","TQQY","CBTJ","FGDL","BTCI","GLD","XLP","ETCO","QBF","CBTY","SGOL","MAXI","CBXJ","IYJ","SHNY","ZSL","SOXS","SQQQ","BK4550","XAGUSD.FOREX","XBTY","BCCC","BITY","XLF","BTCO","BK4547","MNRS","CBOA","YBTC","DULL","QQQM","RETL","EZBC","UNG","NAPR","CBXY","NDX","AAAU","ETH","BITU","DZZ","IBIT","BFJL","ETQ","VIS","XLV","VHT","IAUI","XLPD","BK4534","FAZ","ARKB","BETH","ESK","GLDY","TQQQ","XLE","GBTC","XLY","HODL","DEFI","IYE","SCO","XAUUSD.FOREX","XRT","CBTO","BETE","BK4561","BAGY","BRRR","SLV","BK4585","QMAR","FAS","IBB","CBXO","BK4593","FBTC","DGP","CBOO","IYH","BTC","NJAN","RTH","SIVR","XBI","BTCZ","LABU","OUNZ","BK4570","GLDM","IYW","NOCT","BTRN","BTCL","TECL","BITI","BITO","IAUM","BTCC","XSD","BK4504","BTCW","USO","XLPU","AGQ","BFAP","BAR","BPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480059","title":"Stringer Reiterates Buy on Ionis as Late-Stage Pipeline Delivers; Price Target Maintained at $86","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480059","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480059?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:55","pubTimestamp":1790182519,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Stringer from Needham maintained...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/stringer-reiterates-buy-on-ionis-as-late-stage-pipeline-delivers-price-target-maintained-at-86-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/stringer-reiterates-buy-on-ionis-as-late-stage-pipeline-delivers-price-target-maintained-at-86-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","BK4585","XBI","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141480","title":"Worldwide Healthcare Trust Boosts Treasury Stock with New Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141480","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141480?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:28","pubTimestamp":1790180888,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ). Worldwide Healthcare Trust PLC has executed a share buyback u...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-new-share-buyback-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-new-share-buyback-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACKY","BRKL","BRKD","XBI","XLV","LU0029874061.USD","BRKU","LU0128526141.USD","BK4588","HCSG","BRKW","BK4581","BK4585","BRKC","BK4137","ACTV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480663","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480663","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480663?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:20","pubTimestamp":1790180400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1018 ET - Roche Holding is expected to move quickly to file for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669848269","title":"Bamboos Health Care Announces Final Dividend for FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669848269","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669848269?lang=en_us&edition=fundamental","pubTime":"2026-09-23 22:40","pubTimestamp":1790174430,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has provided an announcement. Bamboos Health Care Holdings Limited has declared a final ordinary di...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-announces-final-dividend-for-fy2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-announces-final-dividend-for-fy2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486413","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486413","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486413?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:00","pubTimestamp":1790168425,"startTime":"0","endTime":"0","summary":"Healthcare stocks were steady premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF  slightly declining and the iShares Biotechnology ETF  inactive.Roivant Sciences  said its Immunovant  subsidiary plans to stop development of IMVT-1402 in cutaneous lupus erythematosus after a proof-of-concept study failed to achieve statistical significance on the primary endpoint. Shares of Immunovant and Roivant were down 6.1% and 1%, respectively, pre-bell.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","ROIV","XLV","IMVT","LABU","BK4581","BK4139","LU0029874061.USD","BK4585","BK4588","HCSG","PTH","BK4007","LU0128526141.USD","XBI","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669867794","title":"IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2669867794","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669867794?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:00","pubTimestamp":1790168400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Sept.  23, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices, annou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367510/32443/en/iradimed-corporation-to-participate-in-the-5th-annual-roth-healthcare-opportunities-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","BK4581","BK4137","LABU","LU0128526141.USD","BK4082","HCSG","LU0029874061.USD","IRMD","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669648508","title":"Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669648508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669648508?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:30","pubTimestamp":1790166641,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nek...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kymera-therapeutics-kymr-vertex-pharmaceuticals-vrtx-and-nektar-therapeutics-nktr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673428.USD","LU2362541273.HKD","SG9999001176.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU0234570918.USD","BBH","IE00BFTCPJ56.SGD","LU0061475181.USD","NKTR","BIB","IE00B19Z3581.USD","IE0002270589.USD","LU0432979614.USD","LU1069344957.HKD","IBB","BK4585","VERX","VRTX","KYMR","XLV","LU1035775433.USD","IE0002141913.USD","BK4533","IE00B894F039.SGD","IE00BZ9MQY76.HKD","BK4023","LU0289739699.SGD","HCSG","LU0823416689.USD","XBI","LU2362541513.USD","IDNA","LU0109394709.USD","LU1559883803.SGD","BK4139","BK4007","GNMX","LU2417539215.USD","LABU","TBXU","LU0417517546.SGD","PBE","IBBQ","LU0256863811.USD","LU2237438978.USD","LU0757428866.USD","IE00B19Z3B42.SGD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":15,"totalSize":396,"code":"91000000","status":"200"}]}}